SUPERGEN INC (Form: DEFA14A, Received: 04/12
... Company through the website maintained by the SEC at www.sec.gov. In addition, investors and stockholders will be able to obtain free copies of the proxy statement from the Company by contacting Investor Relations by telephone, by going to the Company’s corporate web site at www.SuperGen.com (click ...
... Company through the website maintained by the SEC at www.sec.gov. In addition, investors and stockholders will be able to obtain free copies of the proxy statement from the Company by contacting Investor Relations by telephone, by going to the Company’s corporate web site at www.SuperGen.com (click ...
COMPOUNDING OPHTHALMIC LIQUIDS Y. Pramar, Ph.D
... steam sterilization must be used, for example, validation of the autoclave cycle through the use of biological and other indicators, as well as the use of monitoring devices that track and record time, temperature and pressure. Since steam sterilization uses elevated temperature and pressure, consid ...
... steam sterilization must be used, for example, validation of the autoclave cycle through the use of biological and other indicators, as well as the use of monitoring devices that track and record time, temperature and pressure. Since steam sterilization uses elevated temperature and pressure, consid ...
WARNING: DEATH RELATED TO ULTRA
... Do not prescribe TUZISTRA XR if the patient is taking a monoamine oxidase inhibitor (MAOI) (i.e., certain drugs used for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping a MAOI drug. The use of MAOIs or tricyclic antidepressants with codeine pre ...
... Do not prescribe TUZISTRA XR if the patient is taking a monoamine oxidase inhibitor (MAOI) (i.e., certain drugs used for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping a MAOI drug. The use of MAOIs or tricyclic antidepressants with codeine pre ...
Appendix I 163
... (Anderer et al., 1992). It included ocular artifact minimization based on regression analysis in the time domain, as described by Semlitsch et al. (1986), and automatic artifact rejection based on a time and frequency domain approach as described by Anderer et al. (1987). Validity of the artifact pr ...
... (Anderer et al., 1992). It included ocular artifact minimization based on regression analysis in the time domain, as described by Semlitsch et al. (1986), and automatic artifact rejection based on a time and frequency domain approach as described by Anderer et al. (1987). Validity of the artifact pr ...
Chapter 7 Body Systems
... Using the Physicians’ Drug Reference® (PDR®) or other drug reference guide to list brand and generic names, drug classifications, product identification by shape and color, major precautions, available forms, dosage, and manufacturer. Identifying and describing drug forms. ...
... Using the Physicians’ Drug Reference® (PDR®) or other drug reference guide to list brand and generic names, drug classifications, product identification by shape and color, major precautions, available forms, dosage, and manufacturer. Identifying and describing drug forms. ...
Pilot study of the 5-HT2AR agonist psilocybin in the
... 6-month follow-up. The observed smoking cessation rate substantially exceeds rates commonly reported for other behavioral and/or pharmacological therapies (typically <35%). Although the open-label design does not allow for definitive conclusions regarding the efficacy of psilocybin, these findings s ...
... 6-month follow-up. The observed smoking cessation rate substantially exceeds rates commonly reported for other behavioral and/or pharmacological therapies (typically <35%). Although the open-label design does not allow for definitive conclusions regarding the efficacy of psilocybin, these findings s ...
Inositol: A Scientific Evaluation Of Its Clinical Ef F E C T
... Inositol is a naturally occurring isomer of glucose. It is a key intermediate of a second messenger system used by numerous serotonergic, cholinergic and noradrenergic receptors, making compounds containing inositol important in signal transduction. In addition, inositol is a primary component of ce ...
... Inositol is a naturally occurring isomer of glucose. It is a key intermediate of a second messenger system used by numerous serotonergic, cholinergic and noradrenergic receptors, making compounds containing inositol important in signal transduction. In addition, inositol is a primary component of ce ...
lewy_body_dementia
... Modify tasks. Break tasks into easier steps and focus on success, not failure. Walk together. Taking a walk with the patient with LBD is a win-win activity. Being outdoors and exercising is vital for the health and state of mind—of both of you. Strengthen senses. Have a doctor evaluate each the pati ...
... Modify tasks. Break tasks into easier steps and focus on success, not failure. Walk together. Taking a walk with the patient with LBD is a win-win activity. Being outdoors and exercising is vital for the health and state of mind—of both of you. Strengthen senses. Have a doctor evaluate each the pati ...
GHB, GBL and 1,4-BD Addiction - Trimbos
... system. Chronic exposure to cocaine reduces GABAB receptor activity in the mesocorticolimbic system [80, 81]. GHB may upregulate DA in these former cocaine using alcoholics through reactivation of the GABAB receptor, with a higher propensity for developing craving for and abuse of GHB. 6. RECREATION ...
... system. Chronic exposure to cocaine reduces GABAB receptor activity in the mesocorticolimbic system [80, 81]. GHB may upregulate DA in these former cocaine using alcoholics through reactivation of the GABAB receptor, with a higher propensity for developing craving for and abuse of GHB. 6. RECREATION ...
SAFE Opioid Prescribing: Strategies. Assessment. Fundamentals
... Program Companies. Please see http://ce.er‐la‐opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration. ...
... Program Companies. Please see http://ce.er‐la‐opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration. ...
PDF full-Text - Journal of Investigational Allergology and Clinical
... Hypersensitivity reactions induced by NSAIDs constitute a heterogeneous group of syndromes, in terms of both immunopathogenesis and clinical practice. Several categories can be defined. NSAID-Exacerbated Respiratory Disease The typical patient is an adult with recurrent episodes of asthma and rhinos ...
... Hypersensitivity reactions induced by NSAIDs constitute a heterogeneous group of syndromes, in terms of both immunopathogenesis and clinical practice. Several categories can be defined. NSAID-Exacerbated Respiratory Disease The typical patient is an adult with recurrent episodes of asthma and rhinos ...
SVOP, an Evolutionarily Conserved Synaptic Vesicle Protein
... bacterial sugar transporters that use a proton gradient as a driving force. This led to the hypothesis that SV2 functions to transport an unknown substrate into synaptic and secretory vesicles (Bajjalieh et al., 1992; Feany et al., 1992; Gingrich et al., 1992). Two additional isoforms of SV2 were id ...
... bacterial sugar transporters that use a proton gradient as a driving force. This led to the hypothesis that SV2 functions to transport an unknown substrate into synaptic and secretory vesicles (Bajjalieh et al., 1992; Feany et al., 1992; Gingrich et al., 1992). Two additional isoforms of SV2 were id ...
Safe Handling of Hazardous Drugs
... a drug which displays one or more of the following characteristics: genotoxicity, carcinogenicity, teratogenicity or fertility impairment, or serious organ or other toxic manifestation at low doses in experimental animals or treated patients. The National Institute of Occupational Safety and Health ...
... a drug which displays one or more of the following characteristics: genotoxicity, carcinogenicity, teratogenicity or fertility impairment, or serious organ or other toxic manifestation at low doses in experimental animals or treated patients. The National Institute of Occupational Safety and Health ...
Modafinil And Armodafinil Safety Guide
... available since the late 1970’s. However, they have only become commonly known since the Food and Drug Administration (FDA) approved Modafinil under the brand name Provigil in 1998. Adrafinil (Pronounced ah DRAF i nil) The first commonly available Eugeroic was Adrafinil. It was invented by the Frenc ...
... available since the late 1970’s. However, they have only become commonly known since the Food and Drug Administration (FDA) approved Modafinil under the brand name Provigil in 1998. Adrafinil (Pronounced ah DRAF i nil) The first commonly available Eugeroic was Adrafinil. It was invented by the Frenc ...
2D SMARTCyp Reactivity-Based Site of Metabolism Prediction for
... Research Center, U.S. Army Medical Research and Material Command, Fort Detrick, Maryland 21702, United States S Supporting Information ...
... Research Center, U.S. Army Medical Research and Material Command, Fort Detrick, Maryland 21702, United States S Supporting Information ...
Effects of IV and ICV Hypocretin-1 (Orexin A)
... hypocretin-ligand gene (preprohypocretin gene) knockout mice is similar to that in human and canine narcolepsy.5 In humans, hypocretin-related gene mutations are extremely rare,2 but a deficit in hypocretin transmission is observed in most narcolepsy cases with cataplexy: hypocretin measurements in ...
... hypocretin-ligand gene (preprohypocretin gene) knockout mice is similar to that in human and canine narcolepsy.5 In humans, hypocretin-related gene mutations are extremely rare,2 but a deficit in hypocretin transmission is observed in most narcolepsy cases with cataplexy: hypocretin measurements in ...
Neuroscience of psychoactive substance use and dependence
... attributable to substance use and dependence is the result of a wide variety of health and social problems, including HIV/AIDS, which is driven in many countries by injecting drug use. This neuroscience report is the first attempt by WHO to provide a comprehensive overview of the biological factors ...
... attributable to substance use and dependence is the result of a wide variety of health and social problems, including HIV/AIDS, which is driven in many countries by injecting drug use. This neuroscience report is the first attempt by WHO to provide a comprehensive overview of the biological factors ...
intravenous buprenorphine in humans
... mg dose were not significantly greater than those after the 0.6 mg dose. It appears that a plateau exists for these measures. Further increases in the dose of buprenorphine may not increase these effects. A decrease of effect could occur, as it does for electroencephalographic,35 analgesic,2 and ope ...
... mg dose were not significantly greater than those after the 0.6 mg dose. It appears that a plateau exists for these measures. Further increases in the dose of buprenorphine may not increase these effects. A decrease of effect could occur, as it does for electroencephalographic,35 analgesic,2 and ope ...
formulation and evaluation of ibuprofen suppositories
... supply, absence of villi and a relatively small surface area (0.020.05 m2). Rectum also contains a small volume of viscous fluid (0.5-1.25 ml) spread over the surface with limited buffer capacity. Rectal route of administration is specifically useful for infants and children who have difficulty in s ...
... supply, absence of villi and a relatively small surface area (0.020.05 m2). Rectum also contains a small volume of viscous fluid (0.5-1.25 ml) spread over the surface with limited buffer capacity. Rectal route of administration is specifically useful for infants and children who have difficulty in s ...
Dear Sir/Madam - University of Michigan College of Pharmacy
... Development of New Medicine IND, IB, NDA, MAA filing, IB preparation, and product registration: o Pregabalin (Lyrica, CI-1008) and backups (CI-1045, PD 299685, etc.) o Gabapentin (Neurontin, CI-945) o Gabapentin and naproxen combination (CI-1032) o Antiobesity project: Cobalt mesoporpherin (PD 160 ...
... Development of New Medicine IND, IB, NDA, MAA filing, IB preparation, and product registration: o Pregabalin (Lyrica, CI-1008) and backups (CI-1045, PD 299685, etc.) o Gabapentin (Neurontin, CI-945) o Gabapentin and naproxen combination (CI-1032) o Antiobesity project: Cobalt mesoporpherin (PD 160 ...
Mash-Summary-Ibogain..
... Ibogaine has a variety of dose-dependent pharmacological actions that opiate deand t stimulan psycho and cation detoxifi opiate relevant to its effectiveness for gical studies pendence, but may influence considerations for safety. However, toxicolo , given at conducted in primates have demonstrated ...
... Ibogaine has a variety of dose-dependent pharmacological actions that opiate deand t stimulan psycho and cation detoxifi opiate relevant to its effectiveness for gical studies pendence, but may influence considerations for safety. However, toxicolo , given at conducted in primates have demonstrated ...
Salvia Divinorum: Establish Restrictions But Don`t Criminalize It
... Salvia] seems much shorter than for most other drugs, including alcohol.”xiii There are no reported cases of Salvia poisoning or overdose. Research to date has failed to establish acute or chronic toxicity of Salvia in humans.xiv No poisoning injuries or deaths have been reported as a result of Salv ...
... Salvia] seems much shorter than for most other drugs, including alcohol.”xiii There are no reported cases of Salvia poisoning or overdose. Research to date has failed to establish acute or chronic toxicity of Salvia in humans.xiv No poisoning injuries or deaths have been reported as a result of Salv ...
Dissolution Stability of Cephalexin Extemporaneous Suspensions
... evaluated. The CE concentration measured in the assay of each formulation remained within 90% of the labeled amount throughout the stability study (Table 1). ANOVA was used to establish differences among the assay average results during the storage period. Statistically significant differences were ...
... evaluated. The CE concentration measured in the assay of each formulation remained within 90% of the labeled amount throughout the stability study (Table 1). ANOVA was used to establish differences among the assay average results during the storage period. Statistically significant differences were ...
product monograph serc
... combination with other overdosed drugs. Standard overdose protocol / supportive measures should be followed. ...
... combination with other overdosed drugs. Standard overdose protocol / supportive measures should be followed. ...
problem amphetamine and methamphetamine use in
... amphetamines, cocaine, ecstasy, piperazines or new stimulant drugs such as mephedrone. Finally, Europe is an important producer of amphetamines with several countries reporting illicit production facilities on their territory. The provision of care for those with amphetamines problems is another are ...
... amphetamines, cocaine, ecstasy, piperazines or new stimulant drugs such as mephedrone. Finally, Europe is an important producer of amphetamines with several countries reporting illicit production facilities on their territory. The provision of care for those with amphetamines problems is another are ...